Dexmedetomidine for Conscious Sedation and Controlled Hypotension in Head and Neck Surgery: A Single-Centre Experience
Open Access
Abstract
Background and Objectives: Elderly patients with head and neck tumours frequently present with multiple comorbidities and a potentially difficult airway, making general anaesthesia high-risk. Dexmedetomidine, a selective alpha-2 adrenoceptor agonist, provides conscious sedation without clinically significant respiratory depression, offering a compelling locoregional alternative. This study evaluated the haemodynamic profile, sedation kinetics, and satisfaction outcomes of a standardised dexmedetomidine-based protocol for head and neck surgery under local infiltration anaesthesia. Materials and Methods: A prospective, single-centre observational study was conducted at the University Hospital Centre Zagreb. Twenty-three consecutive adult patients received a continuous dexmedetomidine infusion at 0.5 μg/kg/h, initiated preoperatively in the post-anaesthesia care unit without a loading dose. Haemodynamic parameters, sedation-to-incision interval, cumulative dose, and postoperative patient and surgeon satisfaction (NRS 1–10) were recorded. Spearman rank-order correlation and the Mann–Whitney U test were used for statistical analysis. Results: The primary outcome of haemodynamic stability—defined as the absence of vasoactive or inotropic rescue—was achieved in all 23 patients (100%). The median cumulative dexmedetomidine dose was 52 μg (IQR 44–68 μg). Controlled hypotension was achieved in all patients, with a median nadir systolic blood pressure of 98 mmHg. Supplemental oxygen was required in only 2 of 23 patients (8.7%). Patient and surgeon satisfaction reached a median NRS score of 10 in both groups. The sedation-to-incision interval correlated with total drug dose (ρ = 0.74, p < 0.001), consistent with fixed-rate infusion pharmacokinetics. Hypertensive patients exhibited a greater reduction in systolic blood pressure (median 45 vs. 28 mmHg; p = 0.015). Conclusions: A fixed-rate dexmedetomidine infusion initiated in the post-anaesthesia care unit provides a feasible and potentially effective conscious sedation strategy for head and neck surgery under local infiltration anaesthesia in selected elderly and comorbid patients. In this pilot series, the protocol was associated with haemodynamic stability in all cases, low supplemental oxygen requirements, and high procedural satisfaction among both patients and surgeons. These findings are preliminary and require confirmation in larger, controlled studies.Keywords
This publication has 45 references indexed in Scilit:
- Epithelial head and neck cancer survival in Europe: geographical variation, time trends and long term survival.European Journal of Cancer, 2025
- Management of Older Patients with Head and Neck Cancer: A Comprehensive ReviewAdvances in Therapy, 2023
- Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trialsIntensive Care Medicine, 2022
- Long-term glucocorticoids for rheumatoid arthritisCochrane Database of Systematic Reviews, 2021
- Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysisBritish Journal of Anaesthesia, 2019
- Galanin Neurons Unite Sleep Homeostasis and α2-Adrenergic SedationCurrent Biology, 2019
- Dexmedetomidine metabolic clearance is not affected by fat mass in obese patientsBritish Journal of Anaesthesia, 2018
- Clinical Pharmacokinetics and Pharmacodynamics of DexmedetomidineClinical Pharmacokinetics, 2017
- Perioperative dexmedetomidine for acute pain after abdominal surgery in adultsCochrane Database of Systematic Reviews, 2016
- Dexmedetomidine pharmacokinetics in the obeseEuropean Journal of Clinical Pharmacology, 2015